For adults with chronic kidney disease in type 2 diabetes (CKD in T2D)

Mobile Terms
and Conditions

Bayer KERENDIA Savings Program SMS (text) messages are recurring automated savings program or free trial voucher program messages, which may include savings alerts, refill reminders, and other messages related to your participation in the savings program or free trial voucher program. These SMS messages are sent through PSKW, LLC dba ConnectiveRx a service provider partner operating on behalf of Bayer. 

When you opt-in to the service, we will send you an SMS message to confirm your signup. By providing your cell phone number, you represent that you are the authorized user of the wireless device you use to receive the messages and that you are authorized to approve any changes. Bayer reserves the right to alter these terms and conditions or discontinue the messaging at any time and at its sole discretion, may add or delete a cellular carrier from this program at any time, without notice. Text messages you receive as part of this program are automated and your responses are not read by any person. Consent to receiving SMS messages is not a requirement to participating in the Bayer KERENDIA Savings Program and may opt out at any time. Please visit Bayer’s privacy policy or contact us for additional information. Please visit the full terms and conditions regarding participation eligibility in the Bayer KERENDIA Savings program.

Message and data rates may apply. While we do not charge you for the messages, your mobile service provider may charge you for SMS text messages as a part of your contract or service. Please contact your mobile service provider for details.

Message frequency varies.

To stop receiving messages, reply STOP at any time.

For help, reply HELP or call [908-731-8240].

We are able to deliver on most of the major and minor carriers (i.e Verizon, Sprint, AT&T, T-Mobile and MetroPCS). If you are unsure whether your carrier supports short codes, please contact your wireless provider directly

***Carriers are not liable for delayed or undelivered messages***

Patients are eligible for the co-pay card if they are commercially insured and may pay as little as $0 and save up to $3,000 per year. Patients who are enrolled in any type of government insurance or reimbursement programs are not eligible. As a condition precedent of the co-payment support provided under this program, e.g., co-pay refunds, participating patients and pharmacies are obligated to inform insurance companies and third-party payers of any benefits they receive and the value of this program, and may not participate if this program is prohibited by or conflicts with their private insurance policy, as required by contract or otherwise. Void where prohibited by law, taxed, or restricted. Patients enrolled in the Bayer US Patient Assistance Foundation are not eligible. Bayer may determine eligibility, monitor participation, equitably distribute product and modify or discontinue any aspect of the KERENDIA $0 Co-Pay Program at any time, including but not limited to this commercial co-pay assistance program.

KERENDIA free trial voucher may provide new patients with up to a 30-day supply of KERENDIA and must be accompanied by a valid, signed prescription for KERENDIA. This offer is valid only in the United States and Puerto Rico. Voucher Program shall not apply in any state or jurisdiction where prohibited. KERENDIA supplied free of charge through the Voucher Program is not contingent on continued use of KERENDIA or any other prescriptions or use of Bayer products. No claim for reimbursement for product dispensed pursuant to this voucher may be submitted to any patient or third-party payer whether a commercial or a government payer. Not valid if reproduced. It is unlawful for any person to sell, purchase, trade, barter or export KERENDIA supplied through the voucher program or make an offer to do so. This free-trial voucher cannot be combined with any other rebate/offer, free trial or similar offer for the specified prescription. Limit 1 voucher per patient. You must be 18 years old or older. Bayer reserves the right to change or discontinue this Voucher Program at any time without notice.

See more + See less -
See more + See less -
See more + See less -

What is KERENDIA?

KERENDIA is a prescription medicine used to treat chronic kidney disease in adults with type 2 diabetes to reduce the risk of:

  • Worsening of kidney disease
  • Kidney failure
  • Death due to cardiovascular disease
  • Heart attack
  • Hospitalization for heart failure

Important Safety Information

Do not take KERENDIA if you:
  • Have problems with your adrenal glands
  • Take certain medications called CYP3A4 inhibitors. Ask your healthcare provider if you are not sure if you are taking any of these medications
Before you take KERENDIA, tell your healthcare provider about all your medical conditions, including if you:
  • Have high potassium levels in your blood (hyperkalemia) or take medications that may increase potassium levels in your blood. KERENDIA can cause hyperkalemia. Your healthcare provider will check your potassium levels before and during treatment with KERENDIA
  • Have severe liver problems
  • Are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Avoid breastfeeding during treatment with KERENDIA and 1 day after treatment
Tell your healthcare provider about all the prescription and over-the-counter medicines you take, including: salt substitutes, vitamins, and herbal or potassium supplements.
  • KERENDIA may affect the way other medications work, and other medications may affect how KERENDIA works. Do not start or stop any medicine before you talk with your healthcare provider. Avoid grapefruit or grapefruit juice as it may increase KERENDIA levels in the blood
The most common side effects of KERENDIA include:
  • Hyperkalemia (potassium level in your blood that is higher than normal)
  • Hypotension (blood pressure that is lower than normal)
  • Hyponatremia (sodium level in your blood that is lower than normal)

Please see the Prescribing Information for KERENDIA.

Important Safety Information

Do not take KERENDIA if you:
  • Have problems with your adrenal glands
  • Take certain medications called CYP3A4 inhibitors. Ask your healthcare provider if you are not sure if you are taking any of these medications
Before you take KERENDIA, tell your healthcare provider about all your medical conditions, including if you:
  • Have high potassium levels in your blood (hyperkalemia) or take medications that may increase potassium levels in your blood. KERENDIA can cause hyperkalemia. Your healthcare provider will check your potassium levels before and during treatment with KERENDIA
  • Have severe liver problems
  • Are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Avoid breastfeeding during treatment with KERENDIA and 1 day after treatment
Tell your healthcare provider about all the prescription and over-the-counter medicines you take, including: salt substitutes, vitamins, and herbal or potassium supplements.
  • KERENDIA may affect the way other medications work, and other medications may affect how KERENDIA works. Do not start or stop any medicine before you talk with your healthcare provider. Avoid grapefruit or grapefruit juice as it may increase KERENDIA levels in the blood
The most common side effects of KERENDIA include:
  • Hyperkalemia (potassium level in your blood that is higher than normal)
  • Hypotension (blood pressure that is lower than normal)
  • Hyponatremia (sodium level in your blood that is lower than normal)

Please see the Prescribing Information for KERENDIA.